Nakaya A - Search Results

1

Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.

Onda Y, Kanda J, Kaneko H, Shimura Y, Fuchida SI, Nakaya A, Itou T, Yamamura R, Tanaka H, Shibayama H, Shimazu Y, Uchiyama H, Yoshihara S, Adachi Y, Matsuda M, Hanamoto H, Uoshima N, Kosugi S, Ohta K, Yagi H, Kanakura Y, Matsumura I, Hino M, Nomura S, Shimazaki C, Takaori-Kondo A, Kuroda J; Kansai Myeloma Forum. Onda Y, et al. Among authors: nakaya a. Ther Adv Hematol. 2022 Jun 24;13:20406207221104584. doi: 10.1177/20406207221104584. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35785245 Free PMC article.

2

[Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder in a Patient with Acute Lymphocytic Leukemia].

Azuma Y, Nakaya A, Fujita S, Hotta M, Fujita Y, Yoshimura H, Nakanishi T, Satake A, Ito T, Ishii K, Nomura S. Azuma Y, et al. Among authors: nakaya a. Gan To Kagaku Ryoho. 2015 Aug;42(8):1005-7. Gan To Kagaku Ryoho. 2015. PMID: 26321719 Japanese.

3

Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report.

Fujita Y, Nakaya A, Fujita S, Hotta M, Yoshimura H, Azuma Y, Nakanishi T, Satake A, Ishii K, Ito T, Nomura S. Fujita Y, et al. Among authors: nakaya a. Mol Clin Oncol. 2016 Feb;4(2):151-153. doi: 10.3892/mco.2015.695. Epub 2015 Dec 7. Mol Clin Oncol. 2016. PMID: 26893851 Free PMC article.

4

Retrospective analysis of bevacizumab-induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer.

Nakaya A, Kurata T, Yokoi T, Iwamoto S, Torii Y, Katashiba Y, Ogata M, Hamada M, Kon M, Nomura S. Nakaya A, et al. Cancer Med. 2016 Jul;5(7):1381-7. doi: 10.1002/cam4.701. Epub 2016 Apr 25. Cancer Med. 2016. PMID: 27109438 Free PMC article.

5

Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia.

Azuma Y, Nakaya A, Hotta M, Fujita S, Tsubokura Y, Yoshimura H, Satake A, Ishii K, Ito T, Nomura S. Azuma Y, et al. Among authors: nakaya a. Mol Clin Oncol. 2016 Jul;5(1):31-34. doi: 10.3892/mco.2016.864. Epub 2016 Apr 20. Mol Clin Oncol. 2016. PMID: 27330760 Free PMC article.

6

Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S. Nakaya A, et al. Leuk Res Rep. 2016 Jun 29;6:24-6. doi: 10.1016/j.lrr.2016.06.003. eCollection 2016. Leuk Res Rep. 2016. PMID: 27489766 Free PMC article.

7

[Second primary malignancies among patients with myeloma-related-diseases in the KMF database].

Kosugi S, Shibayama H, Nakatani E, Kida T, Ohta K, Kaneko H, Yagi H, Tanaka H, Fuchida S, Nakaya A, Kobayashi M, Kuroda J, Kamitsuji Y, Uoshima N, Adachi Y, Tsudo M, Shimazaki C, Nomura S, Hino M, Matsumura I, Taniwaki M, Kanakura Y, Takaori-Kondo A. Kosugi S, et al. Among authors: nakaya a. Rinsho Ketsueki. 2016 Jul;57(7):839-47. doi: 10.11406/rinketsu.57.839. Rinsho Ketsueki. 2016. PMID: 27498726 Japanese.

8

[Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].

Esaki M, Ishii K, Azuma Y, Tsubokura Y, Yoshimura H, Hotta M, Nakanishi T, Fujita S, Nakaya A, Satake A, Ito T, Nomura S. Esaki M, et al. Among authors: nakaya a. Rinsho Ketsueki. 2016 Jul;57(7):854-8. doi: 10.11406/rinketsu.57.854. Rinsho Ketsueki. 2016. PMID: 27498728 Japanese.

9

Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.

Tsubokura Y, Satake A, Hotta M, Yoshimura H, Fujita S, Azuma Y, Nakanishi T, Nakaya A, Ito T, Ishii K, Nomura S. Tsubokura Y, et al. Among authors: nakaya a. Int J Hematol. 2016 Dec;104(6):744-748. doi: 10.1007/s12185-016-2087-y. Epub 2016 Aug 29. Int J Hematol. 2016. PMID: 27573760

10

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan.

Yoshimura H, Hotta M, Nakanishi T, Fujita S, Nakaya A, Satake A, Ito T, Ishii K, Nomura S. Yoshimura H, et al. Among authors: nakaya a. J Blood Med. 2017 Jan 24;8:5-12. doi: 10.2147/JBM.S123374. eCollection 2017. J Blood Med. 2017. PMID: 28182150 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters